“Statistical Interpretation of the RV144 HIV Vaccine Efficacy Trial in Thailand: a Case Study for Statistical Issues in Efficacy Trials”, J Infect Dis, vol. 203, pp. 969-975, 2011.
, “Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials.”, J Infect Dis, vol. 203, no. 7, pp. 969-75, 2011.
, “Statistical aspects of intraperitoneal chemotherapy studies.”, Semin Oncol, vol. 12, no. 3 Suppl 4, pp. 121-3, 1985.
, , “Standardization and validation issues of the ELISPOT assay.”, Methods Mol Biol, vol. 302, pp. 51-86, 2005.
, “Standardization and Validation Issues of the ELISPOT Assay”, Methods Mol Biol, vol. 302, pp. 51-86, 2005.
, “The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study System for Evaluation of Optical Coherence Tomograms: SCORE Study Report 4”, Arch Ophthalmol, vol. 127, pp. 1461-1467, 2009.
, “Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study system for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE Study Report 9.”, Arch Ophthalmol, vol. 128, no. 9, pp. 1140-5, 2010.
, “Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study System for Evaluation of Stereoscopic Color Fundus Photographs and Fluorescein Angiograms: SCORE Study Report 9”, Archives of Ophthalmology, vol. 128, pp. 1140-1145, 2010.
, “The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4.”, Arch Ophthalmol, vol. 127, no. 11, pp. 1461-7, 2009.
, “Stability of undiluted and diluted vaccinia-virus vaccine, Dryvax.”, J Infect Dis, vol. 187, no. 8, pp. 1319-22, 2003.
, “Stability of Undiluted and Diluted Vaccinia-Virus Vaccine, Dryvax”, J Infectious Diseases, vol. 187, pp. 1319-1322, 2003.
, “Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration.”, Ophthalmology, vol. 120, no. 1, pp. 140-50, 2013.
, “Spectral-Domain Optical Coherence Tomography Characteristics of Intermediate Age-Related Macular Degeneration”, Opthalmology, vol. 120, pp. 140-150, 2013.
, “Spectral Domain Optical Coherence Tomography Predictors of Visual Acuity in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2).”, Ophthalmol Retina, 2020.
, “Specifying methods for mean VA calculations.”, J Cataract Refract Surg, vol. 36, no. 1, pp. 184-5; author reply 185, 2010.
, “Specifying Methodes for Mean VA Calculations [letter]”, J Cataract Refract Surg, vol. 36, pp. 184-185, 2010.
, “Spatial Correlation Between Hyperpigmentary Changes on Color Fundus Photography and Hyperreflective Foci on SDOCT in Intermediate AMD”, Invest Ophthalmol Vis Sci, vol. 53, pp. 4626-4633, 2012.
, “Spatial correlation between hyperpigmentary changes on color fundus photography and hyperreflective foci on SDOCT in intermediate AMD.”, Invest Ophthalmol Vis Sci, vol. 53, no. 8, pp. 4626-33, 2012.
, “Solid tumors following kidney transplantation in children.”, Pediatr Transplant, vol. 17, no. 8, pp. 726-30, 2013.
, “Sleep assessment in a randomized trial of hyperbaric oxygen in U.S. service members with post concussive mild traumatic brain injury compared to normal controls.”, Sleep Med, vol. 51, pp. 66-79, 2018.
, , “Sirolimus Is Associated With Veno-Occlusive Disease of the Liver After Myeloablative Allogeneic Stem Cell Transplantation”, Blood, vol. 112, pp. 4425-4431, 2008.
, “Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation.”, Blood, vol. 112, no. 12, pp. 4425-31, 2008.
,